India's government grapples with a massive rice surplus, exceeding four times the required stock. Despite offering a large quantity for ethanol production, there are no takers. To address this, the government considers lowering the sale price for distilleries and potentially allowing sugar exports to manage the excess stock.
Related news
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, received a positive CHMP opinion for its filgrastim biosimilar, Zefylti, intended to treat neutropenia and mobilize peripheral progenitor cells. Zefylti is CuraTeQ's first biosimilar to receive this positive opinion. Three additional biosimilars are currently under review with EMA and UK-MHRA, expected to be available next year.
Sebi has rejected Digvijay Gaekwad's application to make a competing offer for Religare Enterprises, citing insufficient proof of financial resources and non-compliance with a Supreme Court order. This clears the path for the Burmans, who are the largest shareholders, to gain control of the company.
Tata stakeholders are considering appointing a retired Supreme Court chief justice as arbitrator to determine trustee appointments for the Ratan Tata Endowment Foundation.
Global capability centres (GCCs) are increasingly recruiting talent from IT services companies, with up to 48% of their workforce now sourced from these firms. Offering higher salaries, GCCs attract professionals in emerging tech areas and are expanding recruitment efforts to new locations within India.
PAN 2.0: PAN cardholders can get a reprinted card with a QR code. The reprint costs Rs 50. The income tax department will send the new card to your registered email address.
NPS Vatsalya offers parents a way to secure their children's financial future, including retirement, with a pension scheme for minors. Notable features include a market-linked voluntary contribution system and a unique PRAN for account management. Minimum initial investment is Rs 1,000.
India's trade deficit hit a 42-month low at $14 billion in February 2025, primarily due to a slowdown in imports to $51 billion. Despite global uncertainties and fluctuating petroleum prices, exports slightly declined to $36.9 billion, with non-petroleum products driving growth in the trade sector.
Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio, including UNLOXCYT, an FDA-approved treatment for advanced skin cancer, expanding its global presence in oncology treatments.
US President Donald Trump's approach in the second term on tariff announcements have been perceived by markets as a more gradualist approach compared to his earlier aggressive campaign rhetoric, says a report by Union Bank of India.
US industrial production fared much better than expected last month, the Federal Reserve said Friday, rising sharply as aircraft manufacturing rebounded after the end of a strike at Boeing. The Fed noted that "the resolution of a work stoppage at a major aircraft manufacturer" helped propel gains in the output of aircraft and parts, a reference to a recent strike at US aviation giant Boeing.